101 Parenteral Bridging Practices and Outcomes in Patients on Warfarin for Mechanical Heart Valves and Venous Thromboembolism
Introduction: Bridging with heparin or low-molecular-weight heparin (LMWH) during warfarin interruption is common. Guidelines against bridging in atrial fibrillation have recently been strengthened, while the evidence against bridging in mechanical heart valves (MHV) and venous thromboembolism (VTE) is less robust. Our objective was to describe the prevalence of bridging in patients on warfarin for MHV or VTE and study post-procedure outcomes.
Authors
- Geoffrey D. Barnes (ORCID: https://orcid.org/0000-0002-6532-8440)
- Mona A. Ali (ORCID: https://orcid.org/0000-0003-2416-6702)
- Xiaowen Kong (ORCID: https://orcid.org/0000-0003-4548-3600)
- James B. Froehlich (ORCID: https://orcid.org/0000-0003-2327-8235)
- Noelle Ryan (ORCID: https://orcid.org/0000-0002-8541-3298)
- Beverly Stallings
- Scott S. Kaatz (ORCID: https://orcid.org/0000-0002-3080-3328)
- Brian Haymart
- Rachel Tang (ORCID: https://orcid.org/0000-0003-1514-2100)
- Gregory D Krol
- Stacy Ellsworth
- Abigail Gredell
- Amy DeLellis
Institutions
- University of Michigan (US)
- Henry Ford Hospital (US)
- Michigan Medicine (US)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.rpth.2025.102793
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00